Canine Atopic Dermatitis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-1983 | Report Format : | Status : Upcoming |

Abstract

Global Canine Atopic Dermatitis Treatment Market: Overview

Canine atopic dermatitis is a problem that is related to the skin, which when exposed to the allergens results in allergic symptoms. The allergens are generally of type pollen, dust, and mites. It is impossible for the pets to be protected from these allergens since when they are outdoors they are exposed to the dust mite and pollens. The common symptoms of this problem are excess scratching, itching, loss of hair, foul odor, rubbing against the carpet, and scaly skin.

Global Canine Atopic Dermatitis Treatment Market: Segmentation

The global market for canine atopic dermatitis treatment is globally fragmented into drugs, mode of administration, and distribution channel. Based on the drugs, the global market is segregated into essential fatty acids, antihistamines, immunosuppressants, corticosteroids, antibiotics, emollients, and others. Based on the mode of administration, the market is categorized into oral, topical, and injectable. Based on the distribution channel, the market is divided into pet clinics, mail order pharmacies, veterinary hospitals, and pet pharmacies.

Global Canine Atopic Dermatitis Treatment Market: Growth Factors

The main factor that is driving the canine atopic dermatitis treatment market is the increasing prevalence of the canine atopic dermatitis across all the regions. Another major factor that is contributing towards the market growth is the ignorance to the canine atopic dermatitis allergic symptoms. Canine atopic dermatitis immunotherapeutic which is been developed helps to reduce the clinical signs that are connected with atopic dermatitis in the dogs. For several weeks the canine atopic dermatitis immunotherapeutic remains in circulation. Canine atopic dermatitis immunotherapeutic is a properly tested method but still needs to be approved by the regulatory bodies. There are certain factors that may cause hindrance to the growth of the market which includes lack in the proper management of the canine atopic dermatitis and severe allergic reactions which may occur due to the side effects of the drugs.

Global Canine Atopic Dermatitis Treatment Market: Regional Analysis

Regional diversification of the canine atopic dermatitis market is given as follows the Middle East & Africa, Eastern Europe, Asia Pacific, Latin America, Western Europe, and North America. The regions that are leading the canine atopic dermatitis treatment market are Europe and North America. The fact that these regions have the high occurrences of canine atopic dermatitis is contributing to the growth of the market. Other factors that attribute to the market growth in these regions include the availability of the advanced veterinary healthcare facilities and the ongoing research and development activities that are opening new opportunities for the market growth in these regions. The Asia Pacific region is also contributing a good market share in the global market.

Global Canine Atopic Dermatitis Treatment Market: Competitive Players

The key market players that are involved in the canine atopic dermatitis treatment market include Zoetis, Virbac, AB Science, Toray Industries, Novartis, Boehringer Ingelheim, Elanco Animal Health, and many others.

Global Canine Atopic Dermatitis Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.